Stephen Maher, PhD

Effect of Tardive Dyskinesia on Quality of Life: Patient-Reported Symptom Severity Is Associated With Physical, Mental, and Social Functioning Deficits

Background: Tardive dyskinesia (TD), an often-irreversible movement disorder typically caused by exposure to antipsychotics, most commonly affects the face, mouth, and tongue, and may be ...

Avery Rizio , PhD;

Jakob Bjorner , MD, PhD;

Stephen Maher , PhD;

Mark Kosinski , DPM, FIDSA, MA;

Sanjay K. Gandhi , MD, PhD;

Joseph McEvoy , MD;

Benjamin Carroll , PharmD;

03/01/2019

Treatment Experiences of Individuals With Schizophrenia: Findings From an Online Survey

Background: This study examined experiences of patients living with schizophrenia with a history of oral antipsychotic medication (OAM) use.

Julia Carpenter-Conlin , MSW;

Leona Bessonova , PhD;

Jakob Bjorner , MD, PhD;

Dawn Velligan , PhD;

Michael Doane , PhD;

Martha Sajatovic , MD;

Stephen Maher , PhD;

Asia Sikora Kessler , PhD;

11/22/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Stephen Maher, PhD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products